Challa TR, Kancharana M, Gunupuram R, Ejjada R, Gunna H, Dora D. A 3% topical gel formulation of tenofovir disoproxil fumarate (TDF) for the treatment of human immunodeficiency virus (HIV) by experimental approach. Curr. Issues Pharm. Med. Sci. [Internet]. 2026 Mar. 31 [cited 2026 Apr. 7];39(1):7-13. Available from: https://czasopisma.umlub.pl/curipms/article/view/3207